Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
The current price of Eli Lilly And Co in the market is Rp 20.875.708,71, with a 24-hour trading volume of Rp 0. The asset's market cap is Rp 18,61P, after moving -1.05% in the last day.
Tokenized Eli Lilly And Co is trading at Rp 20.865.802,28, with a tokenized market cap of Rp 813,08B and a 24-hour trading volume of Rp 34,4B. The tokenized asset has moved -0.63% in the past 24 hours.